Literature DB >> 27048521

Elective neck management for squamous cell carcinoma metastatic to the parotid area lymph nodes.

Michael P Herman1, Robert J Amdur1, John W Werning2, Peter Dziegielewski2, Christopher G Morris1, William M Mendenhall3.   

Abstract

The objective of this study is to determine if radiotherapy (RT) alone to the cervical lymphatics is a suitable alternative to elective neck dissection (END) in patients who undergo parotidectomy and postoperative RT for squamous cell carcinoma metastatic to the parotid area lymph nodes (PALN). We retrospectively reviewed the medical records of 107 patients consecutively treated from November 1969 to March 2012 for cutaneous squamous cell carcinoma metastatic to the PALN with a clinically node-negative neck. Primary therapy consisted of parotidectomy in all cases. We compared regional (cervical) control in two subgroups: 42 patients treated with END and RT and 65 patients treated with elective neck irradiation (ENI) alone. The median time of follow-up was 5.5 years (range 0.3-30 years) for all patients and 11 years for living patients (range 1.8-26 years). There was 1 neck recurrence in each subgroup: END and RT, 1/42 (2 %); and ENI alone, 1/65 (1.5 %). No patient experienced a complication related to neck RT. ENI to a dose of approximately 50-60 Gy is a suitable alternative to END and postoperative RT in patients with squamous cell carcinoma metastatic to the PALN.

Entities:  

Keywords:  Head and neck; Lymph nodes; Parotid; SCCa

Mesh:

Year:  2016        PMID: 27048521     DOI: 10.1007/s00405-016-4021-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  14 in total

Review 1.  Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland--a review of current recommendations.

Authors:  James O'Hara; Alfio Ferlito; Robert P Takes; Alessandra Rinaldo; Primož Strojan; Ashok R Shaha; Juan P Rodrigo; Vinidh Paleri
Journal:  Head Neck       Date:  2010-11-10       Impact factor: 3.147

2.  Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck.

Authors:  Jonathan R Clark; Pavlina Rumcheva; Michael J Veness
Journal:  Ann Surg Oncol       Date:  2012-07-18       Impact factor: 5.344

3.  Assessment of the new nodal classification for cutaneous squamous cell carcinoma and its effect on patient stratification.

Authors:  Markus Brunner; Beverly C Ng; Michael J Veness; Jonathan R Clark
Journal:  Head Neck       Date:  2014-03-25       Impact factor: 3.147

4.  Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.

Authors:  Brian A Moore; Randal S Weber; Victor Prieto; Adel El-Naggar; F Christopher Holsinger; Xian Zhou; J Jack Lee; Scott Lippman; Gary L Clayman
Journal:  Laryngoscope       Date:  2005-09       Impact factor: 3.325

5.  Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck.

Authors:  Tom J Vauterin; Michael J Veness; Garry J Morgan; Michael G Poulsen; Christopher J O'Brien
Journal:  Head Neck       Date:  2006-09       Impact factor: 3.147

6.  Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.

Authors:  Michael J Veness; Gary J Morgan; Carsten E Palme; Val Gebski
Journal:  Laryngoscope       Date:  2005-05       Impact factor: 3.325

7.  Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes.

Authors:  Jennifer L Andruchow; Michael J Veness; Gary J Morgan; Kan Gao; Anthony Clifford; Kerwin F Shannon; Michael Poulsen; Lizbeth Kenny; Carsten E Palme; Patrick Gullane; Christopher Morris; William M Mendenhall; Kepal N Patel; Jatin P Shah; Christopher J O'Brien
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

8.  Pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck.

Authors:  Geva Barzilai; Elhanan Greenberg; Raanan Cohen-Kerem; Ilana Doweck
Journal:  Otolaryngol Head Neck Surg       Date:  2005-06       Impact factor: 3.497

9.  Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.

Authors:  Russell W Hinerman; Daniel J Indelicato; Robert J Amdur; Christopher G Morris; John W Werning; Mikhail Vaysberg; Jessica Kirwan; William M Mendenhall
Journal:  Laryngoscope       Date:  2008-11       Impact factor: 3.325

10.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

View more
  2 in total

1.  Reoperation following the use of non-standardized procedures for malignant parotid tumors.

Authors:  Xiangmin Zhang; Xiangfu Zeng; Xiaolin Lan; Jing Huang; Keqing Luo; Keqiang Tian; Xiuhong Wu; Fufu Xiao; Shaojin Li
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

Review 2.  Current Role of Radiotherapy in the Management of Oral Cavity Squamous Cell Carcinoma.

Authors:  William M Mendenhall; Adam L Holtzman; Roi Dagan; Curtis M Bryant; Kathryn E Hitchcock; Robert J Amdur; Rui P Fernandes
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.